Ervebo Vaccine Delivery Initiated in Response to DRC's Deadliest Ebola Outbreak
Here's what it means for you.
Global health initiatives are ramping up to combat the deadliest Ebola outbreak in DRC, impacting international health protocols and travel.
What happened
On August 21, 2026, over 16,000 doses of the Ervebo Ebola vaccine were delivered to Kinshasa, DRC, as part of a larger allocation to combat a severe outbreak.
The Context
- Deadliest outbreak: The current Ebola outbreak in DRC, driven by the Bundibugyo strain, has resulted in over 5,300 cases and 2,500 deaths since mid-May 2026.
- Vaccine allocation: The World Health Organization (WHO) allocated 70,000 doses of the Ervebo vaccine, with 20,000 earmarked for a Phase 3 clinical trial.
- Health infrastructure challenges: Ongoing armed conflict and infrastructure deficits have complicated containment efforts, necessitating urgent international support.
The Number
— This is the number of Ervebo vaccine doses delivered in the initial shipment, highlighting the scale of the response needed to address the outbreak.
Takeaway
As additional doses are expected, the focus will shift to effective deployment and monitoring of vaccine efficacy in the coming weeks.
Global news coverage with extensive reporting on Middle Eastern conflicts and geopolitics.
"Al Jazeera is a Qatar-based broadcaster known for wide regional coverage and alternative perspectives."
— A47 Editor
More than 16,000 doses of Ervebo vaccine arrive in Ebola-hit DR Congo
More than 16,000 doses of the Ervebo vaccine have arrived in Kinshasa, Democratic Republic of Congo, as part of a larger allocation of 70,000 doses aimed at combating a severe Ebola outbreak that has resulted in significant fatalities and infections.
Comprehensive coverage of Middle Eastern and global issues.
"Al Jazeera is a prominent voice from the Global South, especially the Middle East, with an emphasis on underreported stories."
— A47 Editor
More than 16,000 doses of Ervebo vaccine arrive in Ebola-hit DR Congo
More than 16,000 doses of the Ervebo vaccine have arrived in Kinshasa, Democratic Republic of Congo, as part of a larger allocation of 70,000 doses aimed at combating a severe Ebola outbreak that has resulted in significant fatalities and infections.
Canadian and international health news, medicine, public policy, and research.
"Global News is a mainstream Canadian outlet generally considered to have a centrist editorial stance, covering news with a focus on factual reporting and national interest."
— A47 Editor
Congo to receive 70K doses of Ervebo Ebola vaccine used in past outbreaks
The Democratic Republic of Congo is set to receive 70,000 doses of the Ervebo Ebola vaccine, which has been previously used in past outbreaks, although it is not licensed for the Bundibugyo virus. This shipment comes amid a significant escalation in ...
International coverage of politics, security, and social issues.
"Global News is a mainstream Canadian outlet with a centrist editorial stance, focusing on factual reporting."
— A47 Editor
Congo to receive 70K doses of Ervebo Ebola vaccine used in past outbreaks
The Democratic Republic of Congo is set to receive 70,000 doses of the Ervebo Ebola vaccine, which has been previously used in past outbreaks, although it is not licensed for the Bundibugyo virus. This shipment comes amid a significant escalation in ...
Health, medicine, wellness, and public health coverage with a UAE angle.
"Emirates 24|7 health coverage leans toward accessible reporting on healthcare updates, medical milestones, and wellness topics."
— A47 Editor
Congo to receive 70,000 Ebola vaccine doses as authorities battle fast-spreading outbreak
Congo is set to receive 70,000 doses of the Ervebo Ebola vaccine to combat the rapidly spreading Ebola outbreak, which has been described as the fastest on record. The World Health Organization (WHO) announced this allocation, which includes 20,000 d...